We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,325 hedge funds and large institutions have $339B invested in Johnson & Johnson in 2021 Q2 according to their latest regulatory filings, with 132 funds opening new positions, 1,578 increasing their positions, 1,275 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 132 | Existing positions closed: 76

25% more call options, than puts

Call options by funds: $3B | Put options by funds: $2.41B

24% more repeat investments, than reductions

Existing positions increased: 1,578 | Existing positions reduced: 1,275

17% more capital invested

Capital invested by funds: $291B → $339B (+$48.1B)

0.31% more ownership

Funds ownership: 67.97%68.28% (+0.31%)

0% more funds holding

Funds holding: 3,3173,325 (+8)

21% less funds holding in top 10

Funds holding in top 10: 541427 (-114)

Holders
3,325
Holders Change
+8
Holders Change %
+0.24%
% of All Funds
57.87%
Holding in Top 10
427
Holding in Top 10 Change
-114
Holding in Top 10 Change %
-21.07%
% of All Funds
7.43%
New
132
Increased
1,578
Reduced
1,275
Closed
76
Calls
$3B
Puts
$2.41B
Net Calls
+$593M
Net Calls Change
+$198M
Name Holding Trade Value Shares
Change
Change in
Stake
NP
1326
NorthRock Partners
Minnesota
$5.01M +$193K +1,168 +4%
CIA
1327
Covington Investment Advisors
Pennsylvania
$5.01M +$160K +968 +3%
MIC
1328
Means Investment Company
Maine
$5M +$179K +1,079 +4%
FPCG
1329
Fort Pitt Capital Group
Pennsylvania
$4.99M +$503K +3,038 +11%
KA
1330
Kintegral Advisory
New York
$4.97M
PCIA
1331
Prime Capital Investment Advisors
Kansas
$4.96M +$946K +5,716 +23%
SFA
1332
Sequoia Financial Advisors
Ohio
$4.96M +$542K +3,275 +12%
BJL
1333
Brighton Jones LLC
Washington
$4.95M -$33.6K -203 -0.7%
GCM
1334
Gabalex Capital Management
New York
$4.94M -$4.97M -30,000 -50%
SGA
1335
Sector Gamma AS
Norway
$4.94M
MCCP
1336
Mission Creek Capital Partners
California
$4.94M -$18.5K -112 -0.4%
NDSI
1337
Newman Dignan & Sheerar Inc
Rhode Island
$4.93M -$17.1K -103 -0.3%
FLPIM
1338
F.L. Putnam Investment Management
Massachusetts
$4.93M -$3.81M -23,011 -43%
MPIA
1339
Mountain Pacific Investment Advisers
Idaho
$4.93M -$86.9K -525 -2%
GIA
1340
Gladstone Institutional Advisory
Florida
$4.93M +$2.55M +15,426 +107%
BMA
1341
Brooks Moore & Associates
Tennessee
$4.92M +$7.28K +44 +0.1%
CFMC
1342
Curbstone Financial Management Corp
New Hampshire
$4.92M -$8.28K -50 -0.2%
WWM
1343
Western Wealth Management
Colorado
$4.91M +$1.76M +10,625 +55%
MYLI
1344
Meiji Yasuda Life Insurance
Japan
$4.91M -$35.6K -215 -0.7%
NGA
1345
Naples Global Advisors
Florida
$4.91M +$244K +1,476 +5%
OIA
1346
OneDigital Investment Advisors
Kansas
$4.9M -$34.4K -208 -0.7%
TGAM
1347
TBH Global Asset Management
Tennessee
$4.9M +$107K +648 +2%
SCM
1348
Southport Capital Management
Tennessee
$4.89M +$16.4K +99 +0.3%
MS
1349
Marshall & Sullivan
Washington
$4.88M +$60.4K +365 +1%
VLKIM
1350
Van Lanschot Kempen Investment Management
Netherlands
$4.88M +$271K +1,635 +6%

JNJ Hedge Fund Activity: Q2 2021 in Review

3,325 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2021, worth a combined $339B — up 17% from $291B a quarter earlier.

Buyers outnumbered sellers: 132 funds opened new JNJ positions and 76 closed out — a net gain of 56 holders — while 1,578 added to existing stakes and 1,275 trimmed.

The largest buyer was Franklin Resources, adding an estimated $364M. The largest seller was Sanders Capital, cutting an estimated $672M.

  • 3,325 institutional investors held Johnson & Johnson (JNJ) as of Q2 2021, up from 3,317 in Q1 2021.
  • Funds reported $339B of Johnson & Johnson stock for Q2 2021, up 17% quarter-over-quarter.
  • 132 funds opened new Johnson & Johnson positions in Q2 2021 and 76 closed out, a net change of +56 holders.
  • The largest Johnson & Johnson buyer in Q2 2021 was Franklin Resources, an estimated $364M added.
  • The largest Johnson & Johnson seller in Q2 2021 was Sanders Capital, an estimated $672M sold.

Based on aggregated 13F filings for Q2 2021.